Difference between revisions of "Ki-67"
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
| Use = [[typical carcinoid]] versus [[atypical carcinoid]]), grading (gastrointestinal [[neuroendocrine tumours]]) | | Use = [[typical carcinoid]] versus [[atypical carcinoid]]), grading (gastrointestinal [[neuroendocrine tumours]]) | ||
| Subspecial = | | Subspecial = | ||
| Pattern = nuclear staining, membranous pattern | | Pattern = nuclear staining, occasionally membranous pattern ([[pneumocytoma]], [[hyalinizing trabecular tumour]]) | ||
| Positive = | | Positive = | ||
| Negative = | | Negative = | ||
Revision as of 16:54, 2 July 2017
| Ki-67 | |
|---|---|
| Immunostain in short | |
 Ki-67 staining in an anaplastic astrocytoma. | |
| Use | typical carcinoid versus atypical carcinoid), grading (gastrointestinal neuroendocrine tumours) |
| Normal staining pattern | nuclear staining, occasionally membranous pattern (pneumocytoma, hyalinizing trabecular tumour) |
Ki-67 is a very commonly used immunostain that mirror proliferation.
General
- Marker of proliferation.
- Usually nuclear staining.
Membranous staining pattern
- Pneumocytoma has membranous pattern.[1]
- Hyalinizing trabecular tumour.[2]
See also
References
- ↑ Kim, BH.; Bae, YS.; Kim, SH.; Jeong, HJ.; Hong, SW.; Yoon, SO. (Feb 2013). "Usefulness of Ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas.". APMIS 121 (2): 105-10. doi:10.1111/j.1600-0463.2012.02945.x. PMID 23030396.
- ↑ Leonardo, E.; Volante, M.; Barbareschi, M.; Cavazza, A.; Dei Tos, AP.; Bussolati, G.; Papotti, M. (Jun 2007). "Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact?". Appl Immunohistochem Mol Morphol 15 (2): 220-3. doi:10.1097/01.pai.0000213122.66096.f0. PMID 17525638.